User profiles for "author:Andrea Facciabene"
Andrea FacciabeneUniversity of Pennsylvania Verified email at pennmedicine.upenn.edu Cited by 5593 |
T-regulatory cells: key players in tumor immune escape and angiogenesis
A Facciabene, GT Motz, G Coukos - Cancer research, 2012 - AACR
T-regulatory cells (Tregs) are found infiltrating tumors in a vast array of tumor types, and
tumor-infiltrating Tregs are often associated with a poor clinical outcome. Tregs are potent …
tumor-infiltrating Tregs are often associated with a poor clinical outcome. Tregs are potent …
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
A Facciabene, X Peng, IS Hagemann, K Balint… - Nature, 2011 - nature.com
Although immune mechanisms can suppress tumour growth,, tumours establish potent,
overlapping mechanisms that mediate immune evasion,,,. Emerging evidence suggests a …
overlapping mechanisms that mediate immune evasion,,,. Emerging evidence suggests a …
Targeting mitochondria in cancer: current concepts and immunotherapy approaches
An essential advantage during eukaryotic cell evolution was the acquisition of a network of
mitochondria as a source of energy for cell metabolism and contrary to conventional …
mitochondria as a source of energy for cell metabolism and contrary to conventional …
The dark side of tumor-associated endothelial cells
F De Sanctis, S Ugel, J Facciponte… - Seminars in Immunology, 2018 - Elsevier
Angiogenesis is a hallmark of cancer and a requisite that tumors must achieve to fulfill their
metabolic needs of nutrients and oxygen. As a critical step in cancer progression, the …
metabolic needs of nutrients and oxygen. As a critical step in cancer progression, the …
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Anti-CD19 chimeric antigen receptor (CAR) T cell therapy has led to unprecedented
responses in patients with high-risk hematologic malignancies. However, up to 60% of …
responses in patients with high-risk hematologic malignancies. However, up to 60% of …
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
RJ Buckanovich, A Facciabene, S Kim, F Benencia… - Nature medicine, 2008 - nature.com
In spite of their having sufficient immunogenicity, tumor vaccines remain largely ineffective.
The mechanisms underlying this lack of efficacy are still unclear. Here we report a previously …
The mechanisms underlying this lack of efficacy are still unclear. Here we report a previously …
[PDF][PDF] Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors
We investigated the role of chemokines in regulating T cell accumulation in solid tumors.
CCL5 and CXCL9 overexpression was associated with CD8+ T cell infiltration in solid …
CCL5 and CXCL9 overexpression was associated with CD8+ T cell infiltration in solid …
[HTML][HTML] Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response
Alterations in gut microbiota impact the pathophysiology of several diseases, including
cancer. Radiotherapy (RT), an established curative and palliative cancer treatment, exerts …
cancer. Radiotherapy (RT), an established curative and palliative cancer treatment, exerts …
[HTML][HTML] Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12
M Uribe-Herranz, K Bittinger, S Rafail, S Guedan… - JCI insight, 2018 - ncbi.nlm.nih.gov
Adoptive T cell therapy (ACT) is a promising new modality for malignancies. Here, we report
that adoptive T cell efficacy in tumor-bearing mice is significantly affected by differences in …
that adoptive T cell efficacy in tumor-bearing mice is significantly affected by differences in …
Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer
SF Adams, DA Levine, MG Cadungog, R Hammond… - Cancer, 2009 - Wiley Online Library
BACKGROUND: The aim of the study was to determine whether tumor‐infiltrating
lymphocytes and/or tumor mitotic activity could identify subgroups of patients with advanced …
lymphocytes and/or tumor mitotic activity could identify subgroups of patients with advanced …